title: Neuropathy associated with leflunomide: a case series.
authors.forename: K
authors.initials: K
authors.lastname: Martin
authors.forename: F
authors.initials: F
authors.lastname: Bentaberry
authors.forename: C
authors.initials: C
authors.lastname: Dumoulin
authors.forename: M
authors.initials: M
authors.lastname: Longy-Boursier
authors.forename: F
authors.initials: F
authors.lastname: Lifermann
authors.forename: F
authors.initials: F
authors.lastname: Haramburu
authors.forename: J
authors.initials: J
authors.lastname: Dehais
authors.forename: T
authors.initials: T
authors.lastname: Schaeverbeke
authors.forename: B
authors.initials: B
authors.lastname: Bégaud
authors.forename: N
authors.initials: N
authors.lastname: Moore
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007555:Isoxazoles / Q000009:adverse effects*; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide